Cipher Pharmaceuticals Inc.
CPHRF
$10.35
-$0.12-1.11%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 28.99M | 30.87M | 27.33M | 17.36M | 12.14M |
| Total Depreciation and Amortization | 7.17M | 7.20M | 7.22M | 6.94M | 7.07M |
| Total Amortization of Deferred Charges | 179.00K | 166.00K | 159.00K | 153.00K | 136.00K |
| Total Other Non-Cash Items | -8.41M | -10.03M | -10.21M | -5.61M | -5.35M |
| Change in Net Operating Assets | -865.00K | 1.83M | 5.23M | 11.04M | 7.14M |
| Cash from Operations | 27.06M | 30.03M | 29.73M | 29.88M | 21.13M |
| Capital Expenditure | -43.00K | -27.00K | -28.00K | -10.00K | -80.03M |
| Sale of Property, Plant, and Equipment | 198.00K | 198.00K | 130.00K | 130.00K | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -971.00K | -732.00K | -173.00K | -80.00K | -- |
| Cash from Investing | -816.00K | -561.00K | -71.00K | 40.00K | -80.03M |
| Total Debt Issued | -- | -- | -- | 0.00 | 40.00M |
| Total Debt Repaid | -25.31M | -40.31M | -35.31M | -27.29M | -15.33M |
| Issuance of Common Stock | 381.00K | 219.00K | 215.00K | 101.00K | 66.00K |
| Repurchase of Common Stock | -3.24M | -5.38M | -5.38M | -3.72M | -2.14M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -49.00K | -447.00K |
| Cash from Financing | -28.16M | -45.47M | -40.47M | -30.96M | 22.15M |
| Foreign Exchange rate Adjustments | -307.00K | 413.00K | 473.00K | -63.00K | 111.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2.23M | -15.59M | -10.34M | -1.10M | -36.65M |